Security key
92686J106
Viking Therapeutics, Inc. - Common Stock (VKTX)
CUSIP: 92686J106
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 769,601
- Total 13F value
- $1,124,000
- Share change
- +149,913
- SEC-reported price per share
- $1.46
- Number of holders
- 10
- Value change
- +$226,915
- Number of buys
- 6
- Number of sells
- 1
- Shares outstanding
- 115,694,154
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
10
Top holders
10
VKTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Viking Therapeutics, Inc. SEC filings
Viking Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92686J106
Recent filing periods:
Ownership snapshot
Top reported holders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
12/12
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 0.23%
Showing 1-6 of 12 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 0.23%.
12 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
0.23%
RENAISSANCE TECHNOLOGIES LLC
0.14%
SHEPHERD KAPLAN KROCHUK, LLC
0.08%
GEODE CAPITAL MANAGEMENT, LLC
0.03%
GOLDMAN SACHS GROUP INC
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
0.23%
|
$322,000
270,222 shares
|
— | 31 Dec 2016 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.14%
|
$194,000
163,200 shares
|
— | 31 Dec 2016 |
| SHEPHERD KAPLAN KROCHUK, LLC |
13F
Company
|
0.08%
|
$113,000
94,978 shares
|
— | 31 Dec 2016 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.03%
|
$37,000
31,264 shares
|
— | 31 Dec 2016 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.03%
|
$35,000
29,239 shares
|
— | 31 Dec 2016 |
| NORTHERN TRUST CORP |
13F
Company
|
0.01%
|
$20,000
16,962 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
769,601
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
11
Q1 2017 holders
10
Holder diff
-1
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend